Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum

1 May 1986

journal article
research article
Published by SAGE Publications in Annals of Clinical Biochemistry: International Journal of Laboratory Medicine

Vol. 23 (3) , 292-296
https://doi.org/10.1177/000456328602300308

Abstract

An immunoradiometric assay, that uses a monoclonal antibody attached to a solid support and developed for the detection of the ovarian tumour antigen, CA125, in serum, has been evaluated. The method was simple to perform, with reagents having a shelf-life of approximately 4 weeks. The potentials and limitations of this test are discussed.

This publication has 14 references indexed in Scilit:

Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
British Journal of Cancer, 1984
RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA
The Lancet, 1984
Serum haptoglobin and α1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients—a preliminary report
European Journal of Cancer and Clinical Oncology, 1984
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
New England Journal of Medicine, 1983
Biochemical aids in the monitoring of patients with ovarian cancer
Gynecologic Oncology, 1983
Immunopathologic Characterization of a Monoclonal Antibody that Recognizes Common Surface Antigens of Human Ovarian Tumors of Serous, Endometrioid, and Clear Cell Types
American Journal of Clinical Pathology, 1983
Biochemical Markers in Ovarian Cancer: Possibilities and Limitations
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Journal of Clinical Investigation, 1981
Epithelial Carcinoma of the Ovary: Current Strategies
Annals of Internal Medicine, 1981
Analysis of human ovarian tumor antigens using heterologous antisera: Detection of new antigenic systems
International Journal of Cancer, 1978